http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101273918-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate | 2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101273918-B1 |
| titleOfInvention | Human anti-epithelial growth factor receptor FA antibody and pharmaceutical composition for tumor treatment comprising the same |
| abstract | The present invention relates to human anti-epithelial growth factor receptor Fab antibodies. In the present invention, the high-affinity anti-EGFR human Fab antibody selected by the DVS-II method includes a heavy chain variable region and a light chain variable region selected by screening, thereby specificizing the epidermal growth factor receptor. As a result, it is possible to provide a pharmaceutical composition for treating tumors and a pharmaceutical composition for treating rectal cancer. |
| priorityDate | 2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.